BACKGROUND:Intermediate cognitive phenotypes (ICPs) are measurable and quantifiable states that may be objectively assessed in a standardized method, and can be integrated into association studies, including genetic, biochemical, clinical, and imaging based correlates. The present study used neuropsychological measures as ICPs, with factor scores in executive functioning, attention, memory, fine motor function, and emotion processing, similar to prior work in schizophrenia. METHODS:Healthy control subjects (HC, n=34) andeuthymic (E, n=66), depressed (D, n=43), or hypomanic/mixed (HM, n=13) patients with bipolar disorder (BD) were assessed with neuropsychological tests. These were from eight domains consistent with previous literature; auditory memory, visual memory, processing speed with interference resolution, verbal fluency and processing speed, conceptual reasoning and set-shifting, inhibitory control, emotion processing, and fine motor dexterity. RESULTS: Of the eight factor scores, the HC group outperformed the E group in three (Processing Speed with Interference Resolution, Visual Memory, Fine Motor Dexterity), the D group in seven (all except Inhibitory Control), and the HM group in four (Inhibitory Control, Processing Speed with Interference Resolution, Fine Motor Dexterity, and Auditory Memory). LIMITATIONS: The HM group was relatively small, thus effects of this phase of illness may have been underestimated. Effects of medication could not be fully controlled without a randomized, double-blind, placebo-controlled study. CONCLUSIONS: Use of the factor scores can assist in determining ICPs for BD and related disorders, and may provide more specific targets for development of new treatments. We highlight strong ICPs (Processing Speed with Interference Resolution, Visual Memory, Fine Motor Dexterity) for further study, consistent with the existing literature. Copyright (c) 2009 Elsevier B.V. All rights reserved.
RCT Entities:
BACKGROUND: Intermediate cognitive phenotypes (ICPs) are measurable and quantifiable states that may be objectively assessed in a standardized method, and can be integrated into association studies, including genetic, biochemical, clinical, and imaging based correlates. The present study used neuropsychological measures as ICPs, with factor scores in executive functioning, attention, memory, fine motor function, and emotion processing, similar to prior work in schizophrenia. METHODS: Healthy control subjects (HC, n=34) and euthymic (E, n=66), depressed (D, n=43), or hypomanic/mixed (HM, n=13) patients with bipolar disorder (BD) were assessed with neuropsychological tests. These were from eight domains consistent with previous literature; auditory memory, visual memory, processing speed with interference resolution, verbal fluency and processing speed, conceptual reasoning and set-shifting, inhibitory control, emotion processing, and fine motor dexterity. RESULTS: Of the eight factor scores, the HC group outperformed the E group in three (Processing Speed with Interference Resolution, Visual Memory, Fine Motor Dexterity), the D group in seven (all except Inhibitory Control), and the HM group in four (Inhibitory Control, Processing Speed with Interference Resolution, Fine Motor Dexterity, and Auditory Memory). LIMITATIONS: The HM group was relatively small, thus effects of this phase of illness may have been underestimated. Effects of medication could not be fully controlled without a randomized, double-blind, placebo-controlled study. CONCLUSIONS: Use of the factor scores can assist in determining ICPs for BD and related disorders, and may provide more specific targets for development of new treatments. We highlight strong ICPs (Processing Speed with Interference Resolution, Visual Memory, Fine Motor Dexterity) for further study, consistent with the existing literature. Copyright (c) 2009 Elsevier B.V. All rights reserved.
Authors: Outi M Palo; Mervi Antila; Kaisa Silander; William Hennah; Helena Kilpinen; Pia Soronen; Annamari Tuulio-Henriksson; Tuula Kieseppä; Timo Partonen; Jouko Lönnqvist; Leena Peltonen; Tiina Paunio Journal: Hum Mol Genet Date: 2007-08-02 Impact factor: 6.150
Authors: Andrea Poyastro Pinheiro; Richard S E Keefe; Tara Skelly; Megan Olarte; Keren Leviel; Leslie A Lange; Ethan M Lange; T Scott Stroup; Jeffrey Lieberman; Patrick F Sullivan Journal: Aust N Z J Psychiatry Date: 2007-02 Impact factor: 5.744
Authors: R Rodriguez-Jimenez; J Hoenicka; M A Jimenez-Arriero; G Ponce; A Bagney; M Aragues; T Palomo Journal: Neuropsychobiology Date: 2007-01-17 Impact factor: 2.328
Authors: David J Schretlen; Nicola G Cascella; Stephen M Meyer; Lisle R Kingery; S Marc Testa; Cynthia A Munro; Ann E Pulver; Paul Rivkin; Vani A Rao; Catherine M Diaz-Asper; Faith B Dickerson; Robert H Yolken; Godfrey D Pearlson Journal: Biol Psychiatry Date: 2006-12-11 Impact factor: 13.382
Authors: Jill M Thompson; John M Gray; John H Hughes; Stuart Watson; Allan H Young; I Nicol Ferrier Journal: Bipolar Disord Date: 2007-08 Impact factor: 6.744
Authors: Scott A Langenecker; Angela F Caveney; Bruno Giordani; Elizabeth A Young; Kristy A Nielson; Lisa J Rapport; Linas A Bieliauskas; Matthew J Mordhorst; Sheila Marcus; Naomi Yodkovik; Kevin Kerber; Stanley Berent; Jon-Kar Zubieta Journal: Psychiatry Res Date: 2007-04-19 Impact factor: 3.222
Authors: Katherine E Burdick; Birgit Funke; Joseph F Goldberg; John A Bates; Judith Jaeger; Raju Kucherlapati; Anil K Malhotra Journal: Bipolar Disord Date: 2007-06 Impact factor: 6.744
Authors: Zahi N Karam; Emily Mower Provost; Satinder Singh; Jennifer Montgomery; Christopher Archer; Gloria Harrington; Melvin G Mcinnis Journal: Proc IEEE Int Conf Acoust Speech Signal Process Date: 2014-07-14
Authors: Natania A Crane; Alvaro Vergés; Masoud Kamali; Runa Bhaumik; Kelly A Ryan; David F Marshall; Erika F H Saunders; Michelle T Kassel; Anne L Weldon; Melvin G McInnis; Scott A Langenecker Journal: Assessment Date: 2018-02-06
Authors: Simon J Evans; Rachel N Ringrose; Gloria J Harrington; Peter Mancuso; Charles F Burant; Melvin G McInnis Journal: J Psychiatr Res Date: 2014-06-12 Impact factor: 4.791
Authors: Aaron C Vederman; Sara L Weisenbach; Lisa J Rapport; Hadia M Leon; Brennan D Haase; Lindsay M Franti; Michael-Paul Schallmo; Erika F H Saunders; Masoud M Kamali; Jon-Kar Zubieta; Scott A Langenecker; Melvin G McInnis Journal: Cortex Date: 2011-05-11 Impact factor: 4.027
Authors: Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker Journal: Early Interv Psychiatry Date: 2015-07-14 Impact factor: 2.732
Authors: Kelly A Ryan; Erica L Dawson; Michelle T Kassel; Anne L Weldon; David F Marshall; Kortni K Meyers; Laura B Gabriel; Aaron C Vederman; Sara L Weisenbach; Melvin G McInnis; Jon-Kar Zubieta; Scott A Langenecker Journal: Brain Date: 2015-03-28 Impact factor: 13.501
Authors: Sara L Weisenbach; Lisa J Rapport; Emily M Briceno; Brennan D Haase; Aaron C Vederman; Linas A Bieliauskas; Robert C Welsh; Monica N Starkman; Melvin G McInnis; Jon-Kar Zubieta; Scott A Langenecker Journal: Soc Cogn Affect Neurosci Date: 2012-11-29 Impact factor: 3.436
Authors: Kelly A Ryan; Shervin Assari; Kaley Angers; David F Marshall; Kristin Hinrichs; Rebecca Easter; Pallavi Babu; Bethany D Pester; Scott A Langenecker; Melvin G McInnis Journal: Bipolar Disord Date: 2017-09-14 Impact factor: 6.744